IFNA1 and cancer: These scenarios support the notion that PRR-mediated activation of type I-IFN responses occurs throughout tumorigenesis, and may force the cancer cell to hamper such responses in order to escape the anti-proliferative and the immune-stimulatory effects of IFN signaling.